Clinical Trial Detail

NCT ID NCT04367311
Title Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors >= 4cm), IIA, IIB, and Select IIIA [T3N1, T4N0-1] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Nasser Hanna
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Cisplatin + Pemetrexed Disodium

Atezolizumab + Cisplatin + Docetaxel

Age Groups: adult senior

Additional content available in CKB BOOST